Shattuck Labs (STTK) Free Cash Flow (2019 - 2026)
Shattuck Labs' (STTK) quarterly Free Cash Flow came in at -$13.5 million in Q1 2026, down 12.09% year-on-year from -$15.3 million in Q1 2025, and down 58.86% on a QoQ basis from -$8.5 million in Q4 2025.
Shattuck Labs (STTK) Free Cash Flow (2019 - 2026) Analysis & Trends
Shattuck Labs (STTK) has 8 years of Free Cash Flow data on file, last reported at -$13.5 million in Q1 2026.
- On a quarterly basis, Free Cash Flow fell 12.09% year-over-year to -$13.5 million in Q1 2026; TTM through Mar 2026 was -$41.4 million, a 26.64% increase from a year earlier, with the FY2025 full-year figure at -$40.0 million, up 34.04% from the prior year.
- Free Cash Flow for Q1 2026 stood at -$13.5 million, down from -$8.5 million in the prior quarter.
- Over the last five years, Free Cash Flow for STTK reached as high as -$8.5 million in Q4 2025 and fell as low as -$38.8 million in Q3 2022.
- Historically, Free Cash Flow has averaged -$17.8 million across 5 years, with a median of -$16.2 million in 2024.
- Across the five-year window, Free Cash Flow slumped 159.89% in 2022 and soared 56.83% in 2023, its largest moves.
- Year by year, Free Cash Flow stood at -$24.5 million in 2022, then grew by 20.78% to -$19.4 million in 2023, then climbed by 10.63% to -$17.4 million in 2024, then jumped by 51.12% to -$8.5 million in 2025, then tumbled by 58.86% to -$13.5 million in 2026.
- Per Business Quant data, the three most recent Free Cash Flow figures were -$13.5 million in Q1 2026, -$8.5 million in Q4 2025, and -$9.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 158.09 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.95 Mn |
| 10 | Shattuck Labs | 795.74 Mn | 795.74 Mn | - | -13.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.49 Mn |
| Mar 31, 2026 | -13.49 Mn |
| Dec 31, 2025 | -8.49 Mn |
| Dec 31, 2025 | -8.49 Mn |
| Sep 30, 2025 | -9.00 Mn |
| Sep 30, 2025 | -9.00 Mn |
| Jun 30, 2025 | -10.43 Mn |
| Jun 30, 2025 | -10.43 Mn |
| Mar 31, 2025 | -12.03 Mn |
| Mar 31, 2025 | -12.03 Mn |
| Dec 31, 2024 | -17.37 Mn |
| Dec 31, 2024 | -17.37 Mn |
| Sep 30, 2024 | -16.11 Mn |
| Sep 30, 2024 | -16.11 Mn |
| Jun 30, 2024 | -10.94 Mn |
| Jun 30, 2024 | -10.94 Mn |
| Mar 31, 2024 | -16.16 Mn |
| Mar 31, 2024 | -16.16 Mn |
| Dec 31, 2023 | -19.44 Mn |
| Dec 31, 2023 | -19.44 Mn |